Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jana Kozáková, Ayça Altay, Vladimír Ždímal, Ludmila Mašková, Fabio Sonvico, Eride Quarta, Alessandra Rossi, Francesca Buttini & Gaia Colombo. (2019) Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction. Drug Development and Industrial Pharmacy 45:10, pages 1664-1673.
Read now
Read now
Zhe Hui Hoo, Rachael Curley, Michael J Campbell, Stephen J Walters, Daniel Hind & Martin J Wildman. (2016) Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate “normative adherence”. Patient Preference and Adherence 10, pages 887-900.
Read now
Read now
Articles from other publishers (18)
Alexy Tran-Dinh, Lina Slassi, Christian De Tymowski, Maksud Assadi, Sébastien Tanaka, Nathalie Zappella, Brice Lortat Jacob, Sylvain Jean-Baptiste, Enora Atchade, Yves Castier, Hervé Mal, Pierre Mordant, Laurence Armand-Lefèvre, Jonathan Messika, Nathalie Grall & Philippe Montravers. (2022) Secondary Prophylaxis With Inhaled Colistin to Prevent Recurrence of Pseudomonas aeruginosa and Extended-spectrum β-lactamase-producing Enterobacterales Pneumonia in ICU After Lung Transplantation: A Before-and-after Retrospective Cohort Analysis. Transplantation 106:11, pages 2232-2240.
Crossref
Crossref
Madeline A Lipp, Ryan L Crass, Linda J Fitzgerald, Twisha S Patel, Richard H Simon, Blair E Lenhan, MeiLan K Han & Shijing Jia. (2022) Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin. Journal of Antimicrobial Chemotherapy 77:9, pages 2516-2521.
Crossref
Crossref
Joana Stokniene, Mathieu Varache, Philip D. Rye, Katja E. Hill, David W. Thomas & Elaine L. Ferguson. (2022) Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment. Scientific Reports 12:1.
Crossref
Crossref
Nasser Alhajj, Niall J. O'Reilly & Helen Cathcart. (2022) Developing ciprofloxacin dry powder for inhalation: A story of challenges and rational design in the treatment of cystic fibrosis lung infection. International Journal of Pharmaceutics 613, pages 121388.
Crossref
Crossref
Elizabeth Marie Gavioli, Nerli GuardadoFarah HaniffNouran DeiabEtty Vider. (2021) Does Cefiderocol Have a Potential Role in Cystic Fibrosis Pulmonary Exacerbation Management?. Microbial Drug Resistance 27:12, pages 1726-1732.
Crossref
Crossref
Marsha Tan, Felisa Reyes-Ortega & Elena K. Schneider-Futschik. (2020) Magnetic Nanoparticle-Based Drug Delivery Approaches for Preventing and Treating Biofilms in Cystic Fibrosis. Magnetochemistry 6:4, pages 72.
Crossref
Crossref
Marsha Tan, Felisa Reyes-Ortega & Elena K. Schneider-Futschik. (2020) Successes and Challenges: Inhaled Treatment Approaches Using Magnetic Nanoparticles in Cystic Fibrosis. Magnetochemistry 6:2, pages 25.
Crossref
Crossref
Jackson R. Hall, Kaitlyn R. Rouillard, Dakota J. Suchyta, Micah D. Brown, Mona Jasmine R. Ahonen & Mark H. Schoenfisch. (2019) Mode of Nitric Oxide Delivery Affects Antibacterial Action. ACS Biomaterials Science & Engineering 6:1, pages 433-441.
Crossref
Crossref
Jackson R. Hall, Sara E. Maloney, Haibao Jin, James B. Taylor & Mark H. Schoenfisch. (2019) Nitric oxide diffusion through cystic fibrosis-relevant media and lung tissue. RSC Advances 9:68, pages 40176-40183.
Crossref
Crossref
Veronica B. Hubble, Brittany A. Hubbard, Bradley M. Minrovic, Roberta J. Melander & Christian Melander. (2018)
Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against
Pseudomonas aeruginosa
. ACS Infectious Diseases 5:1, pages 141-151.
Crossref
Crossref
Burkhard Tümmler. (2019) Emerging therapies against infections with Pseudomonas aeruginosa. F1000Research 8, pages 1371.
Crossref
Crossref
Titiaan E Post, Ingrid M C Kamerling, Richard C J M van Rossen, Jacobus Burggraaf, Jasper Stevens, Anneke C Dijkmans, Harry G M Heijerman, Daan J Touw, Annelies J van Velzen & Erik B Wilms. (2018) Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration. European Journal of Hospital Pharmacy 25:6, pages 337-339.
Crossref
Crossref
Maizbha U Ahmed, Tony Velkov, Qi Tony Zhou, Alex J Fulcher, Judy Callaghan, Fanfan Zhou, Kim Chan, Mohammad A K Azad & Jian Li. (2018) Intracellular localization of polymyxins in human alveolar epithelial cells. Journal of Antimicrobial Chemotherapy.
Crossref
Crossref
Manolya Kukut Hatipoglu, Anthony J. Hickey & Lucila Garcia-Contreras. (2018) Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs. International Journal of Pharmaceutics 549:1-2, pages 306-316.
Crossref
Crossref
Nivedita Shetty, Patricia Ahn, Heejun Park, Sonal Bhujbal, Dmitry Zemlyanov, Alex Cavallaro, Sharad Mangal, Jian Li & Qi Tony Zhou. (2018) Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin. Molecular Pharmaceutics 15:9, pages 4004-4020.
Crossref
Crossref
Valeri V. Mossine, Deborah L. Chance, James K. Waters & Thomas P. Mawhinney. (2018) Interaction of Bacterial Phenazines with Colistimethate in Bronchial Epithelial Cells. Antimicrobial Agents and Chemotherapy 62:8.
Crossref
Crossref
Xiaoming Liu, Shanyu Gao & Huile Xu. (2018) lncRNAPCAT29 inhibits pulmonary fibrosis via the TGF‑β1‑regulated RASAL1/ERK1/2 signal pathway. Molecular Medicine Reports.
Crossref
Crossref
Alan Abdulla, Roelof W.F. van Leeuwen, Aurelia H.M. de Vries Schultink & Birgit C.P. Koch. (2015) Stability of colistimethate sodium in a disposable elastomeric infusion device. International Journal of Pharmaceutics 486:1-2, pages 367-369.
Crossref
Crossref